Rates of symptomatic venous thromboembolism in US surgical patients: A retrospective administrative database study

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 4, 2009, Pages 458-464

  Spyropoulos, Alex C ^a   Hussein, Mohammed ^b   Lin, Jay ^c   Battleman, David ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b IQVIA   (United States)

^c SANOFI   (France)

Author keywords

National performance measures; Surgery; Venous thromboembolism

Indexed keywords

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURGICAL PATIENT; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 70350523787     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0351-1     Document Type: Article

References (27)

1. Medicare Quality Improvement Committee SCIP Project Information. Available at: www.medqic.org/scip/. Accessed 17 July 2008
2. The JoinW Commission JCAHO: Available at: www.jointcommission.org. Accessed 17 July 2008
3. U.S. Department of Health and Human Services. The surgeon general's call to action to prevent deep vein thrombosis and pulmonary embolism 2008. Available at: http://www.surgeongeneral.gov/topics/deepvein/calltoaction/ call-to-action-on-dvt-2008.pdf. Accessed 6 October 2008
4. Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT (2007) Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 82:777-782. doi: 10.1002/ajh.20983
5. Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines, 8th edn. Chest 133(6 Suppl):381S-453S
6. Rogers F, Rebuck JA, Sing RF (2007) Venous thromboembolism in trauma: An update for the intensive care unit practitioner. J Intensive Care Med 22:26-37. doi: 10.1177/0885066606295291
7. White RH, Gettner S, Newman JM, Trauner KB, Romano PS (2000) Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med 343:1758-1764. doi: 10.1056/ NEJM200012143432403
8. Gangireddy C, Rectenwald JR, Upchurch GR et al (2007) Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 45:335-341. doi: 10.1016/j.jvs.2006.10.034
9. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ (2007) Venous thromboembolism in the outpatient setting. Arch Intern Med 167:1471-1475. doi: 10.1001/archinte.167.14.1471
10. Friedman RJ (2007) Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty. J Am Acad Orthop Surg 15:148-155
11. Amin AN, Stemkowski S, Lin J, Yang G (2008) Preventing venous thromboembolism in US hospitals: Are surgical patients receiving appropriate prophylaxis? Thromb Haemost 99:796-797
12. United States Department of Health & Human Services. Medical privacy - national standards to protect the privacy of personal health information. Available at: www.hhs.gov/ocr/hipaa. Accessed 12 September 2008
13. United States Department of Health & Human Services. Policy for protection of human research subjects. Available at: http://www.hhs.gov/ ohrp/humansubjects/guidance/45cfr46.htm#46.101. Accessed 17 July 2008
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383. doi: 10.1016/ 0021-9681(87)90171-8
15. Heit JA, Silverstein MD, Mohr DN et al (2000) Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med 160:809-815. doi: 10.1001/archinte.160.6.809
16. Bergqvist D, Agnelli G, Cohen AT et al (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346:975-980. doi: 10.1056/NEJMoa012385
17. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 2009 Jan 21(1):CD004318
18. Friedman RJ, Dunsworth GA (2000) Cost analyses of extended prophylaxis with enoxaparin after hip arthroplasty. Clin Orthop Relat Res 370:171-182. doi: 10.1097/00003086-200001000-00016
19. Bergqvist D, Jönsson B (1999) Cost-effectiveness of prolonged administration of a low molecular weight heparin for the prevention of deep venous thrombosis following total hip replacement. Value Health 2:288-294. doi: 10.1046/j.1524-4733.1999.24003.x
20. Dahl OE, Pleil AM (2003) Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement. J Thromb Haemost 1:896-906. doi: 10.1046/j.1538-7836.2003.00236.x
21. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr, ENDORSE Investigators (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study. Lancet 371:387-394. doi: 10.1016/S0140-6736(08)60202-0
22. Arcelus JI, Monreal M, Caprini JA et al (2008) Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE registry. Thromb Haemost 99:546-551
23. Seddighzadeh A, Zurawska U, Shetty R, Goldhaber SZ (2007) Venous thromboembolism in patients undergoing surgery: Low rates of prophylaxis and high rates of filter insertion. Thromb Haemost 98:1220-1225
24. Centers for Medicare and Medicaid Services CMS Fact Sheet. CMS proposes additions to the list of hospital-acquired condition for fiscal year 2009. 2008. At: http://www.cms.hhs.gov/apps/media/press/ factsheet.asp?Counter=3042&intNumPerPage=10&checkDate= &checkKey=&srchType=1&numDays=3500&srchOpt= 0&srchData=&keywordType=All&chkNewsType=6&intPage= &showAll=&pYear=&year=&desc=false&cboOrder=date. Accessed 6 March 2009
25. Spyropoulos AC, Hurley JS, Ciesla GN, de Lissevoy G (2002) Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin. Chest 122:108-114. doi: 10.1378/chest.122.1.108
26. Spyropoulos AC, Lin J (2007) Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm 13:475-486
27. Heit JA (2006) The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 21:23-29. doi: 10.1007/s11239-006-5572-y